Aldactone therapy in a peritoneal dialysis patient with decreased left ventricular function

Case Reports

Michael J Hausmann et al. Nephrol Dial Transplant. 2002 Nov.

. 2002 Nov;17(11):2035-6.

doi: 10.1093/ndt/17.11.2035.

No abstract available

Comment in

Aldactone therapy in a peritoneal dialysis patient.
Azar R, Hogede L, Carru V. Azar R, et al. Nephrol Dial Transplant. 2003 Jun;18(6):1232; author reply 1232-3. doi: 10.1093/ndt/gfg088. Nephrol Dial Transplant. 2003. PMID: 12748367 No abstract available.
Aldactone therapy in a peritoneal dialysis patient.
Fenwick S, Bell GM. Fenwick S, et al. Nephrol Dial Transplant. 2003 Jun;18(6):1232; author reply 1232-3. doi: 10.1093/ndt/gfg098. Nephrol Dial Transplant. 2003. PMID: 12748369 No abstract available.

The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.
Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes J. Pitt B, et al. N Engl J Med. 1999 Sep 2;341(10):709-17. doi: 10.1056/NEJM199909023411001. N Engl J Med. 1999. PMID: 10471456 Clinical Trial.